Medical Service Wing of Central India Institute of Medical Sciences (CIIMS) has signed a Memorandum of Understanding (MoU) with RedLotus Pharmtech Pvt. Ltd (RPPL), which has a collective experience in technology transfer and validation and also has a supply chain.
CIIMS is doing extensive research on the development of diagnostic kits, products, reagents, methods etc. from the last two decades. The developed product/kits transferred to bedside for accurate diagnosis and better treatment. The CIIMS has now decided to transfer the technologies to RedLotus so that they eventually reach all corners of society, said Dr Rajpal Singh Kashyap, Director, Research of CIIMS. The MOU will help both the parties to facilitate commercialization of research products developed by clinical scientists in CIIMS Research Laboratory.
Dr. Lokendra Singh (Director, CIIMS), Dr. Rajpal Singh Kashyap (Director, Research, CIIMS), Mr. Pravin Tapadia ji (Secretary, CIIMS), Dr. H. F. Daginawala (Honorary Research Consultant, CIIMS), Dr. Amit Nayak (Research Scientist, CIIMS), Dr. Aliabbas Husain (Junior Research Scientist, CIIMS), Mr. Manish Bhatkar (Founder, CEO, RPPL), Mr. Vijay Sharma (Director Marketing, Shivayu Ayurved Limited) and Mr. Satish Sarda (Chartered Accountant) were present during a small ceremony of signing the MoU.
👉 Click here to read the latest Gujarat news on TheLiveAhmedabad.com